Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03371368 · ClinicalTrials.gov registry record · NA
Metabolism and Bariatric Surgery Study
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03371368: Completed NA study, sponsored by Columbia University.
NCT03371368 is a NA study that has completed, run by Columbia University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03371368, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if diet-induced weight loss causes different changes in hormones that control appetite and glucose control than surgery-induced weight loss. The overall research plan is a non-randomized prospective study of 3 different weight loss (WL) interventions and a lean and an obese healthy control group.
Primary Outcome
A linear mixed effects model will be used to compare the cortisol changes between the LCD and the surgery groups. Specifically, cortisol change will be modeled as longitudinal outcome, and the main predictors are time and treatment group, and the time-treatment interaction.
Interventions
- PROCEDURE Roux-en-Y Gastric Bypass (RYGBP)
- PROCEDURE Sleeve Gastrectomy (SG)
- BEHAVIORAL Very Low Calorie Diet (VLCD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2023-04-24 |
| Phase | NA |
What the finished NCT03371368 record still lists
NCT03371368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Roux-en-Y Gastric Bypass (RYGBP) is the first listed.
NCT03371368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03371368 about?
NCT03371368 is a clinical study titled "Metabolism and Bariatric Surgery Study". The purpose of this study is to determine if diet-induced weight loss causes different changes in hormones that control appetite and glucose control than surgery-induced weight loss. The overall research plan is a non-randomized prospective study of 3 different weight loss (WL) interventions and a l...
What is the current status of trial NCT03371368?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2017-10-16. Estimated completion is 2023-04-24.
What interventions are being tested in trial NCT03371368?
The interventions under investigation include: Roux-en-Y Gastric Bypass (RYGBP) (PROCEDURE), Sleeve Gastrectomy (SG) (PROCEDURE), Very Low Calorie Diet (VLCD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03371368?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03371368's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI